ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,57
-0,56%
Dow Jones
39 150,33
0,04%
DAX
18 163,52
-0,41%
Brent Oil
84,39
0,00%
Bitcoin
64 113,50
-0,20%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Anchiano Therapeutics Ltd (ANCN)

  7. Anchiano Therapeutics Ltd (ANCN) Actualités

ANCN

Anchiano Therapeutics (ANCN)

Anchiano Therapeutics Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ANCN
DateHeureSourceTitreSymboleSociété
16/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
19/05/202322h07Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
11/05/202312h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANCNAnchiano Therapeutics Ltd
23/03/202312h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
29/11/202212h17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/11/202222h04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/08/202222h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ANCNAnchiano Therapeutics Ltd
31/05/202216h31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
28/04/202222h07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
25/04/202222h20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ANCNAnchiano Therapeutics Ltd
03/09/202122h05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
18/05/202112h08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ANCNAnchiano Therapeutics Ltd
29/04/202112h23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/04/202123h28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/04/202122h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ANCNAnchiano Therapeutics Ltd
30/03/202113h49Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ANCNAnchiano Therapeutics Ltd
26/03/202121h07Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ANCNAnchiano Therapeutics Ltd
26/03/202113h10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/03/202122h54GlobeNewswire Inc.Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private FinancingNASDAQ:ANCNAnchiano Therapeutics Ltd
09/03/202122h28Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
09/03/202119h01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ANCNAnchiano Therapeutics Ltd
10/02/202119h20Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
13/01/202115h32Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/12/202015h00GlobeNewswire Inc.Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger AgreementNASDAQ:ANCNAnchiano Therapeutics Ltd
21/11/201923h01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
18/11/201912h43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
24/04/201923h22Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
25/03/201921h18Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ANCNAnchiano Therapeutics Ltd
14/03/201913h16GlobeNewswire Inc.Anchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock ExchangeNASDAQ:ANCNAnchiano Therapeutics Ltd
13/02/201914h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:ANCNAnchiano Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:ANCN

Dernières Valeurs Consultées

TG
A3LADJ
Ceske Drahy
EU
QS0018235844
Chine Lung Hai Est Bonds
TG
ZG6C
Ziggo BV
TG
A282HM
CPI Property
LSE
81CA
Rep Belarus 26u
BIT
UB4423
Unicredit Bank
BOV
EUCA4F
EUCATEX PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés